AccuStem Sciences Inc. Amends Accountant Change Filing
Ticker: ACUT · Form: 8-K/A · Filed: Jan 2, 2025 · CIK: 1850767
| Field | Detail |
|---|---|
| Company | Accustem Sciences Inc. (ACUT) |
| Form Type | 8-K/A |
| Filed Date | Jan 2, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, accountant-change, sec-filing
TL;DR
AccuStem Sciences Inc. filed an amendment to its 8-K, updating details about its certifying accountant change from June 17, 2024.
AI Summary
AccuStem Sciences Inc. filed an amendment (8-K/A) on January 2, 2025, to a report originally filed on June 17, 2024. This amendment pertains to a change in the registrant's certifying accountant, with the effective date of this change being June 17, 2024. The company is incorporated in Delaware and its principal executive offices are located at 5 Penn Plaza, New York, NY.
Why It Matters
This filing clarifies a change in AccuStem Sciences Inc.'s independent auditor, which is a significant event for financial reporting and investor confidence.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing clarifying details about a change in certifying accountant, not a new material event.
Key Players & Entities
- AccuStem Sciences Inc. (company) — Registrant
- June 17, 2024 (date) — Date of earliest event reported and effective date of accountant change
- January 2, 2025 (date) — Filing date of the amendment
- 5 Penn Plaza, 19th Floor, #1954 New York, NY 10001 (address) — Principal Executive Offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previous report, specifically to provide updated information regarding a change in the registrant's certifying accountant.
When was the change in the certifying accountant effective?
The change in the registrant's certifying accountant was effective as of June 17, 2024.
What was the original filing date that this amendment relates to?
This amendment (8-K/A) relates to a report originally filed on June 17, 2024.
What is the company's state of incorporation?
AccuStem Sciences Inc. is incorporated in Delaware.
Where are AccuStem Sciences Inc.'s principal executive offices located?
The principal executive offices of AccuStem Sciences Inc. are located at 5 Penn Plaza, 19th Floor, #1954 New York, NY 10001.
Filing Stats: 603 words · 2 min read · ~2 pages · Grade level 13.3 · Accepted 2025-01-02 17:09:07
Filing Documents
- form8-ka.htm (8-K/A) — 39KB
- 0001493152-25-000089.txt ( ) — 212KB
- acut-20240617.xsd (EX-101.SCH) — 3KB
- acut-20240617_lab.xml (EX-101.LAB) — 33KB
- acut-20240617_pre.xml (EX-101.PRE) — 24KB
- form8-ka_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACCUSTEM SCIENCES INC. Date: January 2, 2025 By: /s/ Wendy Blosser Wendy Blosser Chief Executive Officer -4-